

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epithelial cilium movement (GO:0003351) | 8.88568301 |
| 2 | motile cilium assembly (GO:0044458) | 8.67778345 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 8.32425482 |
| 4 | axoneme assembly (GO:0035082) | 6.68001009 |
| 5 | left/right pattern formation (GO:0060972) | 5.86327175 |
| 6 | regulation of cilium movement (GO:0003352) | 5.68486529 |
| 7 | primary alcohol catabolic process (GO:0034310) | 4.86018481 |
| 8 | left/right axis specification (GO:0070986) | 4.63918828 |
| 9 | protein localization to cilium (GO:0061512) | 4.56732780 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.55287588 |
| 11 | central nervous system myelination (GO:0022010) | 4.37681822 |
| 12 | axon ensheathment in central nervous system (GO:0032291) | 4.37681822 |
| 13 | microtubule bundle formation (GO:0001578) | 4.09747363 |
| 14 | intraciliary transport (GO:0042073) | 4.06367079 |
| 15 | ethanol metabolic process (GO:0006067) | 3.97888641 |
| 16 | ventricular system development (GO:0021591) | 3.94681465 |
| 17 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.92735298 |
| 18 | response to xenobiotic stimulus (GO:0009410) | 3.88501562 |
| 19 | regulation of autophagic vacuole assembly (GO:2000785) | 3.86618361 |
| 20 | regulation of microtubule-based movement (GO:0060632) | 3.84354647 |
| 21 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.83822699 |
| 22 | cilium organization (GO:0044782) | 3.78619018 |
| 23 | neuronal action potential propagation (GO:0019227) | 3.77583915 |
| 24 | cilium assembly (GO:0042384) | 3.67687720 |
| 25 | diterpenoid biosynthetic process (GO:0016102) | 3.67347470 |
| 26 | vitamin transmembrane transport (GO:0035461) | 3.59200489 |
| 27 | regulation of vacuole organization (GO:0044088) | 3.56640754 |
| 28 | signal peptide processing (GO:0006465) | 3.53032689 |
| 29 | negative regulation of B cell mediated immunity (GO:0002713) | 3.46234946 |
| 30 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.46234946 |
| 31 | one-carbon compound transport (GO:0019755) | 3.39034284 |
| 32 | regulation of germinal center formation (GO:0002634) | 3.27626283 |
| 33 | negative regulation of humoral immune response (GO:0002921) | 3.27454531 |
| 34 | negative regulation of inclusion body assembly (GO:0090084) | 3.25486461 |
| 35 | cytoplasmic microtubule organization (GO:0031122) | 3.12936976 |
| 36 | microtubule-based movement (GO:0007018) | 3.08118109 |
| 37 | intracellular pH reduction (GO:0051452) | 3.04256051 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.03780133 |
| 39 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.03579045 |
| 40 | protein maturation by protein folding (GO:0022417) | 3.03196964 |
| 41 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.02268903 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.01064146 |
| 43 | cilium morphogenesis (GO:0060271) | 2.99438766 |
| 44 | regulation of interleukin-5 production (GO:0032674) | 2.97618477 |
| 45 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.97503005 |
| 46 | ethanol oxidation (GO:0006069) | 2.96658134 |
| 47 | fatty acid elongation (GO:0030497) | 2.95132044 |
| 48 | neurotransmitter biosynthetic process (GO:0042136) | 2.87045496 |
| 49 | positive regulation of mitochondrial fission (GO:0090141) | 2.86879880 |
| 50 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.86778428 |
| 51 | regulation of interleukin-13 production (GO:0032656) | 2.86651187 |
| 52 | pH reduction (GO:0045851) | 2.84114865 |
| 53 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.79474779 |
| 54 | tolerance induction (GO:0002507) | 2.74707448 |
| 55 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.71641112 |
| 56 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.71293688 |
| 57 | ferric iron transport (GO:0015682) | 2.68696090 |
| 58 | trivalent inorganic cation transport (GO:0072512) | 2.68696090 |
| 59 | negative regulation of interleukin-17 production (GO:0032700) | 2.67898940 |
| 60 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.67175381 |
| 61 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.66475241 |
| 62 | cell projection assembly (GO:0030031) | 2.63302217 |
| 63 | negative regulation of neurotransmitter transport (GO:0051589) | 2.63278130 |
| 64 | glutathione derivative biosynthetic process (GO:1901687) | 2.62749973 |
| 65 | glutathione derivative metabolic process (GO:1901685) | 2.62749973 |
| 66 | skeletal muscle contraction (GO:0003009) | 2.61812192 |
| 67 | sperm capacitation (GO:0048240) | 2.59504882 |
| 68 | retinol metabolic process (GO:0042572) | 2.58850281 |
| 69 | synaptic vesicle exocytosis (GO:0016079) | 2.58468507 |
| 70 | regulation of axon regeneration (GO:0048679) | 2.56734830 |
| 71 | regulation of neuron projection regeneration (GO:0070570) | 2.56734830 |
| 72 | sialylation (GO:0097503) | 2.56367643 |
| 73 | sphingomyelin metabolic process (GO:0006684) | 2.55803592 |
| 74 | respiratory electron transport chain (GO:0022904) | 2.54893722 |
| 75 | synaptic vesicle maturation (GO:0016188) | 2.54000656 |
| 76 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.52990318 |
| 77 | reactive oxygen species biosynthetic process (GO:1903409) | 2.52633453 |
| 78 | phagosome maturation (GO:0090382) | 2.52385643 |
| 79 | electron transport chain (GO:0022900) | 2.52131011 |
| 80 | retinoic acid metabolic process (GO:0042573) | 2.49854482 |
| 81 | myelination (GO:0042552) | 2.48976389 |
| 82 | ensheathment of neurons (GO:0007272) | 2.48862123 |
| 83 | axon ensheathment (GO:0008366) | 2.48862123 |
| 84 | carnitine metabolic process (GO:0009437) | 2.48663385 |
| 85 | respiratory burst (GO:0045730) | 2.46933849 |
| 86 | primary alcohol metabolic process (GO:0034308) | 2.44157112 |
| 87 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.42718571 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 2.42179104 |
| 89 | regulation of inclusion body assembly (GO:0090083) | 2.40716033 |
| 90 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.40652573 |
| 91 | mannosylation (GO:0097502) | 2.40284489 |
| 92 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.38774013 |
| 93 | presynaptic membrane assembly (GO:0097105) | 2.37183283 |
| 94 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.37101007 |
| 95 | creatine metabolic process (GO:0006600) | 2.36763946 |
| 96 | positive regulation of protein depolymerization (GO:1901881) | 2.34413437 |
| 97 | glycosphingolipid biosynthetic process (GO:0006688) | 2.34282952 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.33836042 |
| 99 | detection of calcium ion (GO:0005513) | 2.31915423 |
| 100 | magnesium ion transport (GO:0015693) | 2.31440188 |
| 101 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.28817978 |
| 102 | GPI anchor biosynthetic process (GO:0006506) | 2.28299926 |
| 103 | response to methylmercury (GO:0051597) | 2.28170631 |
| 104 | lung epithelium development (GO:0060428) | 2.28008815 |
| 105 | membrane budding (GO:0006900) | 2.26993757 |
| 106 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.26913058 |
| 107 | multicellular organismal water homeostasis (GO:0050891) | 2.26682177 |
| 108 | presynaptic membrane organization (GO:0097090) | 2.26624064 |
| 109 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.25981786 |
| 110 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.25981786 |
| 111 | ER overload response (GO:0006983) | 2.25966014 |
| 112 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.25813278 |
| 113 | mitochondrion degradation (GO:0000422) | 2.25431623 |
| 114 | terpenoid biosynthetic process (GO:0016114) | 2.24629980 |
| 115 | regulation of synaptic vesicle transport (GO:1902803) | 2.23551411 |
| 116 | response to redox state (GO:0051775) | 2.23318654 |
| 117 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.23046052 |
| 118 | glycosylceramide metabolic process (GO:0006677) | 2.22224062 |
| 119 | neurotransmitter metabolic process (GO:0042133) | 2.20559298 |
| 120 | galactose metabolic process (GO:0006012) | 2.17237155 |
| 121 | regulation of vesicle fusion (GO:0031338) | 2.16578579 |
| 122 | amyloid precursor protein metabolic process (GO:0042982) | 2.16511808 |
| 123 | mast cell activation (GO:0045576) | 2.16223462 |
| 124 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.15845904 |
| 125 | sodium ion homeostasis (GO:0055078) | 2.15734850 |
| 126 | regulation of pigment cell differentiation (GO:0050932) | 2.14403762 |
| 127 | centriole assembly (GO:0098534) | 2.14004874 |
| 128 | negative regulation of amino acid transport (GO:0051956) | 2.13809586 |
| 129 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.13787876 |
| 130 | substantia nigra development (GO:0021762) | 2.12824315 |
| 131 | regulation of interleukin-17 production (GO:0032660) | 2.12801378 |
| 132 | neuron remodeling (GO:0016322) | 2.12690084 |
| 133 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.12243972 |
| 134 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.12243972 |
| 135 | amyloid precursor protein catabolic process (GO:0042987) | 2.11594839 |
| 136 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.11531160 |
| 137 | COPI coating of Golgi vesicle (GO:0048205) | 2.11497575 |
| 138 | Golgi transport vesicle coating (GO:0048200) | 2.11497575 |
| 139 | photoreceptor cell differentiation (GO:0046530) | 2.10845827 |
| 140 | eye photoreceptor cell differentiation (GO:0001754) | 2.10845827 |
| 141 | regulation of cell communication by electrical coupling (GO:0010649) | 2.10429259 |
| 142 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.09500805 |
| 143 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.09418806 |
| 144 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.09418806 |
| 145 | polyketide metabolic process (GO:0030638) | 2.09352294 |
| 146 | doxorubicin metabolic process (GO:0044598) | 2.09352294 |
| 147 | daunorubicin metabolic process (GO:0044597) | 2.09352294 |
| 148 | positive regulation of tolerance induction (GO:0002645) | 2.09296933 |
| 149 | progesterone metabolic process (GO:0042448) | 2.08880674 |
| 150 | water homeostasis (GO:0030104) | 2.08217392 |
| 151 | hydrogen peroxide catabolic process (GO:0042744) | 2.07963984 |
| 152 | protein insertion into membrane (GO:0051205) | 2.07778192 |
| 153 | nucleoside diphosphate metabolic process (GO:0009132) | 2.07301466 |
| 154 | transferrin transport (GO:0033572) | 2.07053950 |
| 155 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.05492692 |
| 156 | eosinophil chemotaxis (GO:0048245) | 2.05427064 |
| 157 | transmission of nerve impulse (GO:0019226) | 2.03255672 |
| 158 | response to epinephrine (GO:0071871) | 2.02986506 |
| 159 | neuron cell-cell adhesion (GO:0007158) | 2.02942987 |
| 160 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.02853716 |
| 161 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.02853716 |
| 162 | sequestering of metal ion (GO:0051238) | 2.01558873 |
| 163 | response to interferon-beta (GO:0035456) | 2.01375239 |
| 164 | protein localization to Golgi apparatus (GO:0034067) | 2.01146575 |
| 165 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.00175309 |
| 166 | axonemal dynein complex assembly (GO:0070286) | 13.5935991 |
| 167 | cilium or flagellum-dependent cell motility (GO:0001539) | 10.6503777 |
| 168 | cilium movement (GO:0003341) | 10.0310471 |
| 169 | regulation of beta-amyloid formation (GO:1902003) | 1.99565970 |
| 170 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 1.99293983 |
| 171 | adult walking behavior (GO:0007628) | 1.98932710 |
| 172 | cellular copper ion homeostasis (GO:0006878) | 1.98449853 |
| 173 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 1.97879206 |
| 174 | GPI anchor metabolic process (GO:0006505) | 1.97812845 |
| 175 | leukocyte degranulation (GO:0043299) | 1.97090899 |
| 176 | inner mitochondrial membrane organization (GO:0007007) | 1.96710445 |
| 177 | response to dietary excess (GO:0002021) | 1.96522428 |
| 178 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 1.95738842 |
| 179 | negative regulation of cation channel activity (GO:2001258) | 1.95350251 |
| 180 | oligodendrocyte differentiation (GO:0048709) | 1.94987291 |
| 181 | dopamine biosynthetic process (GO:0042416) | 1.94876990 |
| 182 | chaperone-mediated protein transport (GO:0072321) | 1.94847389 |
| 183 | preassembly of GPI anchor in ER membrane (GO:0016254) | 1.94308379 |
| 184 | anterograde synaptic vesicle transport (GO:0048490) | 1.92810761 |
| 185 | cellular potassium ion homeostasis (GO:0030007) | 1.92660626 |
| 186 | protein targeting to Golgi (GO:0000042) | 1.92228022 |
| 187 | copper ion homeostasis (GO:0055070) | 1.91974702 |
| 188 | nucleoside diphosphate catabolic process (GO:0009134) | 1.91814882 |
| 189 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 1.91772422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.89026710 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.89680435 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82620057 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.49840156 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.40583249 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16483180 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16053291 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15195549 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01290754 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.97336834 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97143797 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.96538924 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.96396822 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.94381179 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88307314 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.79605355 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.78023567 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76662895 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76438273 |
| 20 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.73740289 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71237530 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71148126 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67775164 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65906071 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65880516 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64772934 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64363406 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.63869155 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63164871 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59695558 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55168870 |
| 32 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54735808 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.54422620 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53515294 |
| 35 | VDR_22108803_ChIP-Seq_LS180_Human | 1.51803375 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45531191 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45531191 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45416740 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44685019 |
| 40 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.42895584 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41999386 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.41716452 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39008883 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38918174 |
| 45 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36451382 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35919220 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35691841 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35491357 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34758887 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34307017 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.33386698 |
| 52 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32140058 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30877431 |
| 54 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29026304 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28190213 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26152288 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26096578 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24621643 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22696845 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22656979 |
| 61 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.22622665 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21164852 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20622650 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19954629 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19835612 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19517243 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19517243 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19406158 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18655384 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18652044 |
| 71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16939641 |
| 72 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16630242 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15928743 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15874706 |
| 75 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13209290 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.12083967 |
| 77 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10230896 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09859445 |
| 79 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09489357 |
| 80 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08557798 |
| 81 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08225939 |
| 82 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07960041 |
| 83 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.06306540 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06237630 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06099423 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03357565 |
| 87 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03288878 |
| 88 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01589517 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01516024 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00925550 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.00185688 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99722053 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99617126 |
| 94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99180041 |
| 95 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98904448 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98563669 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98128766 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98004424 |
| 99 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96551359 |
| 100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96007589 |
| 101 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95360258 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94619448 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94598631 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94496687 |
| 105 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94127806 |
| 106 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93715424 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92578298 |
| 108 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92406117 |
| 109 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91302139 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89946602 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89153600 |
| 112 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88646910 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88601977 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88577609 |
| 115 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88387724 |
| 116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88329110 |
| 117 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87806637 |
| 118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87429010 |
| 119 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87429010 |
| 120 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86597955 |
| 121 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86377626 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86344878 |
| 123 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85030056 |
| 124 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85029715 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84287103 |
| 126 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83104665 |
| 127 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82881018 |
| 128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82401539 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82253609 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80667397 |
| 131 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80127926 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79872700 |
| 133 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79698748 |
| 134 | SPI1_23127762_ChIP-Seq_K562_Human | 0.78993069 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78440152 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.78406477 |
| 137 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78379453 |
| 138 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78370190 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78079144 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78074400 |
| 141 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77863765 |
| 142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77824465 |
| 143 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77621234 |
| 144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77501778 |
| 145 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77365588 |
| 146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77160303 |
| 147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77160303 |
| 148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76897009 |
| 149 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76581470 |
| 150 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.76510162 |
| 151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76340848 |
| 152 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.76264634 |
| 153 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76093678 |
| 154 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76042871 |
| 155 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75768224 |
| 156 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75478959 |
| 157 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75331171 |
| 158 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75257323 |
| 159 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75182128 |
| 160 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74535977 |
| 161 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.74010610 |
| 162 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.73791643 |
| 163 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73059367 |
| 164 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.73020555 |
| 165 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.72909877 |
| 166 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.72833217 |
| 167 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.71086297 |
| 168 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70233183 |
| 169 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70024274 |
| 170 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.69951827 |
| 171 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.69657020 |
| 172 | CBP_21632823_ChIP-Seq_H3396_Human | 0.69441444 |
| 173 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.69410510 |
| 174 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.69182325 |
| 175 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69002089 |
| 176 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.68616524 |
| 177 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.68616524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 4.40516697 |
| 2 | MP0002653_abnormal_ependyma_morphology | 3.63803869 |
| 3 | MP0003880_abnormal_central_pattern | 3.16235499 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.15814949 |
| 5 | MP0002132_abnormal_respiratory_system | 2.81424415 |
| 6 | MP0004270_analgesia | 2.81202432 |
| 7 | MP0000920_abnormal_myelination | 2.80808201 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.67769528 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.56635943 |
| 10 | MP0002277_abnormal_respiratory_mucosa | 2.56119127 |
| 11 | MP0005623_abnormal_meninges_morphology | 2.42257554 |
| 12 | MP0002272_abnormal_nervous_system | 2.08892471 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.08514434 |
| 14 | MP0002064_seizures | 2.03516788 |
| 15 | MP0003724_increased_susceptibility_to | 2.02646377 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 1.98099624 |
| 17 | MP0003195_calcinosis | 1.94206660 |
| 18 | MP0008789_abnormal_olfactory_epithelium | 1.92829659 |
| 19 | MP0009745_abnormal_behavioral_response | 1.87448053 |
| 20 | MP0002332_abnormal_exercise_endurance | 1.87051412 |
| 21 | MP0004043_abnormal_pH_regulation | 1.86169168 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.85964698 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.80594302 |
| 24 | MP0003329_amyloid_beta_deposits | 1.80468417 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.76831978 |
| 26 | MP0001905_abnormal_dopamine_level | 1.76503674 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.76336140 |
| 28 | MP0004133_heterotaxia | 1.76141325 |
| 29 | MP0009046_muscle_twitch | 1.75158730 |
| 30 | MP0004142_abnormal_muscle_tone | 1.73226705 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.72627429 |
| 32 | MP0002736_abnormal_nociception_after | 1.67425846 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.67162006 |
| 34 | MP0000751_myopathy | 1.66890607 |
| 35 | MP0009785_altered_susceptibility_to | 1.66224261 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.64026428 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.63866942 |
| 38 | MP0005310_abnormal_salivary_gland | 1.61601597 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.60424444 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.59590096 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.59374220 |
| 42 | MP0001970_abnormal_pain_threshold | 1.59140679 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.56040898 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.55531795 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.54877596 |
| 46 | MP0003690_abnormal_glial_cell | 1.54120574 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.53981858 |
| 48 | MP0001529_abnormal_vocalization | 1.49358470 |
| 49 | MP0006082_CNS_inflammation | 1.48304659 |
| 50 | MP0001486_abnormal_startle_reflex | 1.46670035 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.44967671 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.43275397 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.39737482 |
| 54 | MP0005409_darkened_coat_color | 1.39080856 |
| 55 | MP0000749_muscle_degeneration | 1.39061843 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.38883689 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.38130292 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.37543440 |
| 59 | MP0002572_abnormal_emotion/affect_behav | 1.37256848 |
| 60 | MP0000604_amyloidosis | 1.35593820 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.34229851 |
| 62 | MP0004510_myositis | 1.33570016 |
| 63 | MP0002063_abnormal_learning/memory/cond | 1.31834928 |
| 64 | MP0003075_altered_response_to | 1.31643208 |
| 65 | MP0005165_increased_susceptibility_to | 1.30700376 |
| 66 | MP0002067_abnormal_sensory_capabilities | 1.30674345 |
| 67 | MP0005671_abnormal_response_to | 1.29689988 |
| 68 | MP0003634_abnormal_glial_cell | 1.29208553 |
| 69 | MP0002419_abnormal_innate_immunity | 1.26995459 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.26457220 |
| 71 | MP0002090_abnormal_vision | 1.26449673 |
| 72 | MP0008260_abnormal_autophagy | 1.25379233 |
| 73 | MP0003633_abnormal_nervous_system | 1.24360545 |
| 74 | MP0002229_neurodegeneration | 1.24335923 |
| 75 | MP0005394_taste/olfaction_phenotype | 1.24083913 |
| 76 | MP0005499_abnormal_olfactory_system | 1.24083913 |
| 77 | MP0004742_abnormal_vestibular_system | 1.21491534 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.21079832 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 1.17777110 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.16666654 |
| 81 | MP0005535_abnormal_body_temperature | 1.16471634 |
| 82 | MP0004484_altered_response_of | 1.14833872 |
| 83 | MP0005025_abnormal_response_to | 1.14206029 |
| 84 | MP0005410_abnormal_fertilization | 1.14149071 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.13404573 |
| 86 | MP0008569_lethality_at_weaning | 1.11975167 |
| 87 | MP0004147_increased_porphyrin_level | 1.11698281 |
| 88 | MP0002638_abnormal_pupillary_reflex | 1.10076467 |
| 89 | MP0002168_other_aberrant_phenotype | 1.09786374 |
| 90 | MP0004130_abnormal_muscle_cell | 1.09594182 |
| 91 | MP0009840_abnormal_foam_cell | 1.09530722 |
| 92 | MP0003879_abnormal_hair_cell | 1.08279101 |
| 93 | MP0001765_abnormal_ion_homeostasis | 1.07900313 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 1.06477348 |
| 95 | MP0001790_abnormal_immune_system | 1.04102644 |
| 96 | MP0005387_immune_system_phenotype | 1.04102644 |
| 97 | MP0000685_abnormal_immune_system | 1.03892949 |
| 98 | MP0003436_decreased_susceptibility_to | 1.03130247 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 1.01520729 |
| 100 | MP0005166_decreased_susceptibility_to | 0.99913148 |
| 101 | MP0002723_abnormal_immune_serum | 0.99382458 |
| 102 | MP0000343_altered_response_to | 0.99103179 |
| 103 | MP0005164_abnormal_response_to | 0.98547102 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.98292606 |
| 105 | MP0000747_muscle_weakness | 0.97795890 |
| 106 | MP0001188_hyperpigmentation | 0.97628781 |
| 107 | MP0001984_abnormal_olfaction | 0.94869490 |
| 108 | MP0003866_abnormal_defecation | 0.94247217 |
| 109 | MP0001542_abnormal_bone_strength | 0.93525778 |
| 110 | MP0002822_catalepsy | 0.93044236 |
| 111 | MP0001270_distended_abdomen | 0.92445117 |
| 112 | MP0005083_abnormal_biliary_tract | 0.92284678 |
| 113 | MP0009379_abnormal_foot_pigmentation | 0.92173446 |
| 114 | MP0003136_yellow_coat_color | 0.91442122 |
| 115 | MP0003303_peritoneal_inflammation | 0.91405170 |
| 116 | MP0002160_abnormal_reproductive_system | 0.91105285 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.89064793 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.87926974 |
| 119 | MP0004883_abnormal_blood_vessel | 0.86708043 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.86639719 |
| 121 | MP0004924_abnormal_behavior | 0.86639719 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.86183018 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.85830717 |
| 124 | MP0004215_abnormal_myocardial_fiber | 0.85781027 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.85564311 |
| 126 | MP0000955_abnormal_spinal_cord | 0.85471719 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.85159096 |
| 128 | MP0004885_abnormal_endolymph | 0.84846532 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.83568992 |
| 130 | MP0003631_nervous_system_phenotype | 0.82797601 |
| 131 | MP0002452_abnormal_antigen_presenting | 0.82335072 |
| 132 | MP0006035_abnormal_mitochondrial_morpho | 0.82120634 |
| 133 | MP0005645_abnormal_hypothalamus_physiol | 0.81687586 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.79819429 |
| 135 | MP0005620_abnormal_muscle_contractility | 0.79653235 |
| 136 | MP0004811_abnormal_neuron_physiology | 0.79294736 |
| 137 | MP0003646_muscle_fatigue | 0.79134122 |
| 138 | MP0005464_abnormal_platelet_physiology | 0.78552456 |
| 139 | MP0005174_abnormal_tail_pigmentation | 0.78018525 |
| 140 | MP0000750_abnormal_muscle_regeneration | 0.77990947 |
| 141 | MP0002295_abnormal_pulmonary_circulatio | 0.76764722 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.76427423 |
| 143 | MP0002269_muscular_atrophy | 0.76077060 |
| 144 | MP0008874_decreased_physiological_sensi | 0.73461428 |
| 145 | MP0005646_abnormal_pituitary_gland | 0.71481277 |
| 146 | MP0004085_abnormal_heartbeat | 0.71172172 |
| 147 | MP0003186_abnormal_redox_activity | 0.70109854 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.68672139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.32755077 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.32755077 |
| 3 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.30350936 |
| 4 | Abnormal ciliary motility (HP:0012262) | 8.97821096 |
| 5 | Rhinitis (HP:0012384) | 8.68421148 |
| 6 | Chronic bronchitis (HP:0004469) | 6.77214269 |
| 7 | Bronchiectasis (HP:0002110) | 6.01371814 |
| 8 | Nasal polyposis (HP:0100582) | 5.79542627 |
| 9 | Abnormality of the nasal mucosa (HP:0000433) | 4.84699670 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.00302657 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.77388170 |
| 12 | Retinal dysplasia (HP:0007973) | 3.65941157 |
| 13 | Bronchitis (HP:0012387) | 3.56013039 |
| 14 | Infertility (HP:0000789) | 3.53418377 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.52823509 |
| 16 | Chronic sinusitis (HP:0011109) | 3.49095876 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.46182779 |
| 18 | Recurrent sinusitis (HP:0011108) | 3.38964233 |
| 19 | Male infertility (HP:0003251) | 3.34412797 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.33785998 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.25523227 |
| 22 | Occipital encephalocele (HP:0002085) | 3.24939226 |
| 23 | Focal motor seizures (HP:0011153) | 3.11618208 |
| 24 | Type II lissencephaly (HP:0007260) | 3.10046466 |
| 25 | Recurrent otitis media (HP:0000403) | 3.07785766 |
| 26 | Hyperactive renin-angiotensin system (HP:0000841) | 3.00851216 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.91196314 |
| 28 | Progressive neurologic deterioration (HP:0002344) | 2.90095681 |
| 29 | Hypothermia (HP:0002045) | 2.88359780 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.87791777 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.87188305 |
| 32 | Visual hallucinations (HP:0002367) | 2.82439452 |
| 33 | Neuroendocrine neoplasm (HP:0100634) | 2.80024679 |
| 34 | Pancreatic fibrosis (HP:0100732) | 2.75029708 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.71016650 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 2.69060959 |
| 37 | True hermaphroditism (HP:0010459) | 2.65738665 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.63439838 |
| 39 | Mitochondrial inheritance (HP:0001427) | 2.63420774 |
| 40 | Pheochromocytoma (HP:0002666) | 2.61514460 |
| 41 | Nonprogressive disorder (HP:0003680) | 2.50998916 |
| 42 | Atelectasis (HP:0100750) | 2.48836157 |
| 43 | Myokymia (HP:0002411) | 2.48534603 |
| 44 | Cerebral hemorrhage (HP:0001342) | 2.44188953 |
| 45 | Axonal loss (HP:0003447) | 2.43661729 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 2.41343429 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.39337387 |
| 48 | Increased muscle lipid content (HP:0009058) | 2.37911634 |
| 49 | Progressive inability to walk (HP:0002505) | 2.37205104 |
| 50 | Progressive macrocephaly (HP:0004481) | 2.35658327 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.33767275 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.31275710 |
| 53 | Atonic seizures (HP:0010819) | 2.31267219 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.31251546 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.31251546 |
| 56 | Acute encephalopathy (HP:0006846) | 2.29322483 |
| 57 | Peripheral hypomyelination (HP:0007182) | 2.26555350 |
| 58 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23872073 |
| 59 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.23841238 |
| 60 | Pancreatic cysts (HP:0001737) | 2.23450991 |
| 61 | Muscle fiber splitting (HP:0003555) | 2.20519506 |
| 62 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18976385 |
| 63 | Gait imbalance (HP:0002141) | 2.17800471 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16742909 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.16742909 |
| 66 | Hepatic necrosis (HP:0002605) | 2.16332054 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.15508343 |
| 68 | Cystic liver disease (HP:0006706) | 2.13201995 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.08105163 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.07888504 |
| 71 | Slow saccadic eye movements (HP:0000514) | 2.07585098 |
| 72 | Loss of speech (HP:0002371) | 2.07497052 |
| 73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07427220 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07427220 |
| 75 | Hyperparathyroidism (HP:0000843) | 2.06495944 |
| 76 | Congenital primary aphakia (HP:0007707) | 2.04513740 |
| 77 | Abnormality of magnesium homeostasis (HP:0004921) | 2.03928876 |
| 78 | Episodic fever (HP:0001954) | 2.02303300 |
| 79 | Anxiety (HP:0000739) | 2.02277034 |
| 80 | Hypomagnesemia (HP:0002917) | 2.00207072 |
| 81 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00129067 |
| 82 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00129067 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.6530920 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.98990350 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98481801 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98481801 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98481801 |
| 88 | Beaking of vertebral bodies (HP:0004568) | 1.97840276 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96029857 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96029857 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96029857 |
| 92 | Large for gestational age (HP:0001520) | 1.93717405 |
| 93 | Increased CSF lactate (HP:0002490) | 1.93230844 |
| 94 | Ankle clonus (HP:0011448) | 1.92892669 |
| 95 | Abnormality of renal resorption (HP:0011038) | 1.92416118 |
| 96 | Clumsiness (HP:0002312) | 1.92407532 |
| 97 | Nephronophthisis (HP:0000090) | 1.92033693 |
| 98 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.91875659 |
| 99 | Stomatitis (HP:0010280) | 1.91533125 |
| 100 | Parakeratosis (HP:0001036) | 1.90726049 |
| 101 | Dysmetria (HP:0001310) | 1.89227270 |
| 102 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89164696 |
| 103 | Dialeptic seizures (HP:0011146) | 1.88273860 |
| 104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88210653 |
| 105 | Hand muscle atrophy (HP:0009130) | 1.87891517 |
| 106 | Absence seizures (HP:0002121) | 1.86082816 |
| 107 | Increased circulating renin level (HP:0000848) | 1.85926721 |
| 108 | Leukodystrophy (HP:0002415) | 1.82870559 |
| 109 | Decreased circulating renin level (HP:0003351) | 1.82831128 |
| 110 | Calf muscle hypertrophy (HP:0008981) | 1.81137797 |
| 111 | Generalized tonic-clonic seizures (HP:0002069) | 1.78500780 |
| 112 | Rigidity (HP:0002063) | 1.78197031 |
| 113 | Onion bulb formation (HP:0003383) | 1.78014972 |
| 114 | Postaxial foot polydactyly (HP:0001830) | 1.77947995 |
| 115 | Mutism (HP:0002300) | 1.77772627 |
| 116 | Sensory axonal neuropathy (HP:0003390) | 1.77055686 |
| 117 | Chronic otitis media (HP:0000389) | 1.75615221 |
| 118 | Psychosis (HP:0000709) | 1.73558439 |
| 119 | Optic disc pallor (HP:0000543) | 1.72641528 |
| 120 | Hepatosplenomegaly (HP:0001433) | 1.72461308 |
| 121 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72427605 |
| 122 | Epileptic encephalopathy (HP:0200134) | 1.71871051 |
| 123 | Myoclonus (HP:0001336) | 1.71529096 |
| 124 | Focal seizures (HP:0007359) | 1.70071907 |
| 125 | Poor speech (HP:0002465) | 1.69801523 |
| 126 | Hyperkalemia (HP:0002153) | 1.69435694 |
| 127 | Renal salt wasting (HP:0000127) | 1.68917533 |
| 128 | Absent/shortened dynein arms (HP:0200106) | 1.68660483 |
| 129 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.68660483 |
| 130 | Scanning speech (HP:0002168) | 1.68564419 |
| 131 | Tubulointerstitial nephritis (HP:0001970) | 1.67592848 |
| 132 | Exertional dyspnea (HP:0002875) | 1.66488096 |
| 133 | Fetal akinesia sequence (HP:0001989) | 1.65976976 |
| 134 | Choreoathetosis (HP:0001266) | 1.65967925 |
| 135 | Distal lower limb muscle weakness (HP:0009053) | 1.65337770 |
| 136 | Intention tremor (HP:0002080) | 1.65209334 |
| 137 | Action tremor (HP:0002345) | 1.64298734 |
| 138 | Recurrent skin infections (HP:0001581) | 1.63914614 |
| 139 | Spastic gait (HP:0002064) | 1.62963340 |
| 140 | Nephropathy (HP:0000112) | 1.62870994 |
| 141 | Limb-girdle muscle atrophy (HP:0003797) | 1.61498442 |
| 142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.60881304 |
| 143 | Hyperaldosteronism (HP:0000859) | 1.60787511 |
| 144 | Vascular calcification (HP:0004934) | 1.59995016 |
| 145 | Congenital hepatic fibrosis (HP:0002612) | 1.58903396 |
| 146 | Furrowed tongue (HP:0000221) | 1.56027509 |
| 147 | Male pseudohermaphroditism (HP:0000037) | 1.53701405 |
| 148 | Absent speech (HP:0001344) | 1.48814668 |
| 149 | Anencephaly (HP:0002323) | 1.48382180 |
| 150 | Polyphagia (HP:0002591) | 1.47402531 |
| 151 | Exercise-induced myalgia (HP:0003738) | 1.42203944 |
| 152 | Upper limb amyotrophy (HP:0009129) | 1.41000157 |
| 153 | Distal upper limb amyotrophy (HP:0007149) | 1.41000157 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.40965036 |
| 155 | Sclerocornea (HP:0000647) | 1.40738607 |
| 156 | Abnormality of the renal medulla (HP:0100957) | 1.40102040 |
| 157 | Oculomotor apraxia (HP:0000657) | 1.39876395 |
| 158 | Ventricular fibrillation (HP:0001663) | 1.39632267 |
| 159 | Hyponatremia (HP:0002902) | 1.37498501 |
| 160 | Chronic hepatic failure (HP:0100626) | 1.37033343 |
| 161 | Rimmed vacuoles (HP:0003805) | 1.36514079 |
| 162 | Muscle fiber inclusion bodies (HP:0100299) | 1.36124522 |
| 163 | Cardiovascular calcification (HP:0011915) | 1.36112270 |
| 164 | Torticollis (HP:0000473) | 1.36016825 |
| 165 | Limb dystonia (HP:0002451) | 1.35505700 |
| 166 | Recurrent bronchitis (HP:0002837) | 1.35187194 |
| 167 | Focal dystonia (HP:0004373) | 1.33853311 |
| 168 | Hypokalemic alkalosis (HP:0001949) | 1.33735972 |
| 169 | Abnormality of the calf musculature (HP:0001430) | 1.32994760 |
| 170 | Bell-shaped thorax (HP:0001591) | 1.32682117 |
| 171 | Gout (HP:0001997) | 1.32663075 |
| 172 | Mitral stenosis (HP:0001718) | 1.32097389 |
| 173 | Glucose intolerance (HP:0000833) | 1.31315943 |
| 174 | Abnormality of renin-angiotensin system (HP:0000847) | 1.29955105 |
| 175 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.29839890 |
| 176 | Sensorimotor neuropathy (HP:0007141) | 1.27038041 |
| 177 | Hypotension (HP:0002615) | 1.26231688 |
| 178 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.24961825 |
| 179 | Nemaline bodies (HP:0003798) | 1.24500969 |
| 180 | Growth hormone excess (HP:0000845) | 1.22926965 |
| 181 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.22659019 |
| 182 | Postaxial hand polydactyly (HP:0001162) | 1.21765933 |
| 183 | Urinary urgency (HP:0000012) | 1.21342500 |
| 184 | EMG: myopathic abnormalities (HP:0003458) | 1.18787021 |
| 185 | Craniofacial dystonia (HP:0012179) | 1.17783325 |
| 186 | Adrenal overactivity (HP:0002717) | 1.16062864 |
| 187 | Myoglobinuria (HP:0002913) | 1.15505200 |
| 188 | Nuclear cataract (HP:0100018) | 1.14254621 |
| 189 | Depression (HP:0000716) | 1.13894467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.56437906 |
| 2 | TESK1 | 3.53985213 |
| 3 | TNIK | 3.43004217 |
| 4 | STK39 | 2.86385862 |
| 5 | EPHA2 | 2.81758692 |
| 6 | CDK19 | 2.79612712 |
| 7 | LIMK1 | 2.61507051 |
| 8 | ARAF | 2.59847766 |
| 9 | MAPK15 | 2.59444741 |
| 10 | MAPKAPK3 | 2.21138493 |
| 11 | OXSR1 | 2.14416888 |
| 12 | MUSK | 2.10896618 |
| 13 | MAP3K12 | 2.10528127 |
| 14 | CAMKK2 | 2.04532670 |
| 15 | WNK4 | 2.00892527 |
| 16 | NTRK1 | 1.96893026 |
| 17 | EPHA3 | 1.94531941 |
| 18 | MAP3K11 | 1.92829471 |
| 19 | FES | 1.90384022 |
| 20 | MAP3K13 | 1.74851031 |
| 21 | NTRK3 | 1.58854499 |
| 22 | EPHB1 | 1.55747892 |
| 23 | MAP3K3 | 1.51827371 |
| 24 | GRK7 | 1.48337745 |
| 25 | KSR2 | 1.47958237 |
| 26 | MAP2K4 | 1.47407807 |
| 27 | MARK1 | 1.46057157 |
| 28 | EPHA4 | 1.43853674 |
| 29 | BLK | 1.42151515 |
| 30 | PBK | 1.40737429 |
| 31 | MAPKAPK5 | 1.38782115 |
| 32 | ERBB3 | 1.34297835 |
| 33 | MAP3K4 | 1.32510368 |
| 34 | STK38 | 1.31799367 |
| 35 | MAP3K9 | 1.29639544 |
| 36 | KIT | 1.25169691 |
| 37 | ADRBK2 | 1.23357286 |
| 38 | MAP3K1 | 1.23095486 |
| 39 | PIK3CG | 1.15865244 |
| 40 | IRAK4 | 1.14172850 |
| 41 | MAP3K6 | 1.11577221 |
| 42 | CAMK2D | 1.09782061 |
| 43 | IRAK1 | 1.07985419 |
| 44 | TBK1 | 1.07927742 |
| 45 | BMPR2 | 1.04663174 |
| 46 | MAP3K2 | 1.02670249 |
| 47 | CAMK2B | 1.01997041 |
| 48 | GRK5 | 1.01617668 |
| 49 | WNK1 | 0.99404429 |
| 50 | HIPK2 | 0.99325358 |
| 51 | MAP2K7 | 0.99119036 |
| 52 | GRK1 | 0.96869605 |
| 53 | PINK1 | 0.96228623 |
| 54 | UHMK1 | 0.94614555 |
| 55 | TAOK1 | 0.93635904 |
| 56 | DYRK1B | 0.93582197 |
| 57 | IKBKE | 0.92297433 |
| 58 | PDPK1 | 0.90945148 |
| 59 | TEC | 0.90327832 |
| 60 | STK24 | 0.89692471 |
| 61 | NME1 | 0.89577873 |
| 62 | TNK2 | 0.89472059 |
| 63 | TESK2 | 0.89358542 |
| 64 | INSRR | 0.86842468 |
| 65 | PRKCI | 0.86156033 |
| 66 | NEK6 | 0.86073723 |
| 67 | DAPK2 | 0.85994141 |
| 68 | MST4 | 0.85255655 |
| 69 | CSK | 0.83932931 |
| 70 | LMTK2 | 0.83865480 |
| 71 | CAMK2G | 0.82650467 |
| 72 | CASK | 0.82075831 |
| 73 | SYK | 0.82068695 |
| 74 | MAP3K5 | 0.80518348 |
| 75 | TXK | 0.79333111 |
| 76 | PKN1 | 0.79240391 |
| 77 | PDK1 | 0.78581494 |
| 78 | FGR | 0.77873969 |
| 79 | CAMK2A | 0.77844539 |
| 80 | CDK5 | 0.77740958 |
| 81 | TAOK3 | 0.76146508 |
| 82 | PHKG1 | 0.75744087 |
| 83 | PHKG2 | 0.75744087 |
| 84 | CSNK1A1L | 0.74897853 |
| 85 | MINK1 | 0.72834270 |
| 86 | NME2 | 0.72223228 |
| 87 | MAPK13 | 0.71953348 |
| 88 | MYLK | 0.71348211 |
| 89 | MOS | 0.71029582 |
| 90 | SCYL2 | 0.70417301 |
| 91 | DAPK1 | 0.70330496 |
| 92 | MAP4K1 | 0.68845278 |
| 93 | PRKCE | 0.68470754 |
| 94 | IRAK2 | 0.68138683 |
| 95 | CAMKK1 | 0.67366441 |
| 96 | WNK3 | 0.67317247 |
| 97 | RIPK1 | 0.66636797 |
| 98 | CAMK1 | 0.66490382 |
| 99 | ABL2 | 0.65090943 |
| 100 | TIE1 | 0.64638099 |
| 101 | PRKCQ | 0.63257833 |
| 102 | BMPR1B | 0.62030764 |
| 103 | BCKDK | 0.61765222 |
| 104 | PIK3CA | 0.61755959 |
| 105 | RAF1 | 0.61502901 |
| 106 | ZAP70 | 0.61156389 |
| 107 | BCR | 0.59672723 |
| 108 | FER | 0.59088576 |
| 109 | LCK | 0.59041299 |
| 110 | CSNK1G3 | 0.58540899 |
| 111 | CSNK1G1 | 0.58491230 |
| 112 | MAPK12 | 0.58279172 |
| 113 | PAK6 | 0.58127915 |
| 114 | PDK2 | 0.58087821 |
| 115 | OBSCN | 0.58035692 |
| 116 | STK16 | 0.58005291 |
| 117 | LRRK2 | 0.57177665 |
| 118 | PTK2B | 0.56682150 |
| 119 | MAP4K2 | 0.55988591 |
| 120 | FLT3 | 0.55541879 |
| 121 | LYN | 0.53315143 |
| 122 | CSNK1G2 | 0.53041757 |
| 123 | PAK3 | 0.52208704 |
| 124 | PRKG2 | 0.51956241 |
| 125 | PIM2 | 0.51185445 |
| 126 | TYK2 | 0.50622115 |
| 127 | PRKCG | 0.50333444 |
| 128 | TRIM28 | 0.50262076 |
| 129 | GRK6 | 0.48856245 |
| 130 | BTK | 0.48024355 |
| 131 | MARK2 | 0.46538046 |
| 132 | FYN | 0.46254769 |
| 133 | DAPK3 | 0.46197871 |
| 134 | MAP2K6 | 0.44904037 |
| 135 | HCK | 0.44511948 |
| 136 | CSF1R | 0.44403462 |
| 137 | JAK1 | 0.43943589 |
| 138 | MATK | 0.43879828 |
| 139 | AKT2 | 0.43543672 |
| 140 | BRAF | 0.40657010 |
| 141 | PRKCD | 0.40184025 |
| 142 | STK10 | 0.39507966 |
| 143 | PRKACA | 0.39495096 |
| 144 | TAOK2 | 0.36905182 |
| 145 | AURKA | 0.36554899 |
| 146 | PRKCZ | 0.35860019 |
| 147 | PRKD2 | 0.34259630 |
| 148 | ADRBK1 | 0.33148344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.54801707 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.36645213 |
| 3 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.88747483 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.86830762 |
| 5 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.51184220 |
| 6 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.38520946 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.32424343 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.18338264 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.13336639 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11803716 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.07787437 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.01744973 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.94877622 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.93358499 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.88566062 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81800310 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.79874837 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78032169 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66331557 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65589205 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.60772250 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52186486 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.52099094 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.49676788 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.49504460 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47153610 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.45435776 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43789043 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42857840 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42472127 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36971819 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35307776 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.33581968 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.32879362 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.32546578 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.32076686 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31491078 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28313446 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.28227708 |
| 40 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.28138799 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27156467 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.25828435 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.23002150 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21488528 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20068511 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17357883 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15862424 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15701585 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14157170 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.08998950 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07515443 |
| 52 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07239628 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.06393073 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.05112817 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 1.04939375 |
| 56 | Long-term depression_Homo sapiens_hsa04730 | 1.00387616 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.99152441 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97734029 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97470466 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95965755 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94831107 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94052569 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91483773 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91135979 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.89799890 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89653912 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89586562 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88297183 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87486760 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86286968 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86218643 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85182113 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84215716 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.82373723 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.82104311 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80404275 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.79717294 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75771048 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.74496845 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.74188089 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74035168 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72883309 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72178139 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71085231 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70690460 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68672163 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68383493 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68338712 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67781465 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67261880 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67204366 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67113839 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64801430 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.63695432 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62977811 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62315203 |
| 97 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62274869 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62104903 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61977454 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.61934829 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61388942 |
| 102 | Prion diseases_Homo sapiens_hsa05020 | 0.59804274 |
| 103 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59653165 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.59111781 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58904960 |
| 106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58499926 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57873137 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56414213 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56193482 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.56123195 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55621940 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53485350 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53348955 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52816641 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.52584424 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51498152 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51117583 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50700016 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.50605678 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.48748263 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47525704 |
| 122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47268918 |
| 123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47148022 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47065258 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46822695 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46817564 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46564566 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46222944 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46096220 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44716026 |
| 131 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43777848 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43240394 |
| 133 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42339596 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40877252 |
| 135 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40229959 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.40205260 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39874059 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.39765945 |
| 139 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38211857 |
| 140 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38171261 |
| 141 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36506749 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36451781 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35770573 |

